Tenaya Therapeutics Inc (TNYA)
4.56
-0.12
(-2.56%)
USD |
NASDAQ |
May 06, 16:00
4.54
-0.02
(-0.44%)
After-Hours: 20:00
Tenaya Therapeutics Enterprise Value: 253.39M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 253.39M |
| May 03, 2024 | 262.81M |
| May 02, 2024 | 258.10M |
| May 01, 2024 | 262.81M |
| April 30, 2024 | 251.82M |
| April 29, 2024 | 251.82M |
| April 26, 2024 | 233.76M |
| April 25, 2024 | 226.70M |
| April 24, 2024 | 239.26M |
| April 23, 2024 | 244.75M |
| April 22, 2024 | 243.18M |
| April 19, 2024 | 234.55M |
| April 18, 2024 | 232.19M |
| April 17, 2024 | 232.98M |
| April 16, 2024 | 245.54M |
| April 15, 2024 | 246.32M |
| April 12, 2024 | 245.54M |
| April 11, 2024 | 263.60M |
| April 10, 2024 | 247.11M |
| April 09, 2024 | 251.04M |
| April 08, 2024 | 258.89M |
| April 05, 2024 | 263.60M |
| April 04, 2024 | 254.96M |
| April 03, 2024 | 271.45M |
| April 02, 2024 | 255.75M |
| Date | Value |
|---|---|
| April 01, 2024 | 287.15M |
| March 28, 2024 | 306.00M |
| March 27, 2024 | 300.50M |
| March 26, 2024 | 274.59M |
| March 25, 2024 | 276.95M |
| March 22, 2024 | 265.95M |
| March 21, 2024 | 270.66M |
| March 20, 2024 | 280.09M |
| March 19, 2024 | 251.04M |
| March 18, 2024 | 273.81M |
| March 15, 2024 | 285.98M |
| March 14, 2024 | 269.88M |
| March 13, 2024 | 320.13M |
| March 12, 2024 | 331.12M |
| March 11, 2024 | 328.77M |
| March 08, 2024 | 397.86M |
| March 07, 2024 | 390.01M |
| March 06, 2024 | 413.56M |
| March 05, 2024 | 429.27M |
| March 04, 2024 | 414.35M |
| March 01, 2024 | 419.06M |
| February 29, 2024 | 353.51M |
| February 28, 2024 | 349.66M |
| February 27, 2024 | 345.04M |
| February 26, 2024 | 333.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-74.15M
Minimum
Nov 08 2022
984.50M
Maximum
Aug 27 2021
206.82M
Average
146.42M
Median
Aug 08 2023
Enterprise Value Benchmarks
| Adverum Biotechnologies Inc | 124.12M |
| Solid Biosciences Inc | 253.83M |
| Dyne Therapeutics Inc | 1.842B |
| Sana Biotechnology Inc | 1.999B |
| Prime Medicine Inc | 525.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.94M |
| Total Expenses (Quarterly) | 31.45M |
| EPS Diluted (Quarterly) | -0.40 |
| Earnings Yield | -36.62% |